--- a
+++ b/clusters/9knumclustersv2/clust_1397.txt
@@ -0,0 +1,18 @@
+Receipt of anticancer medications or investigational drugs within Protocol-defined time frames.
+Receipt of anticancer medications or investigational drugs within the following intervals before the first administration of study drug:
+Receipt of anticancer chemotherapy within  weeks before the administration of study drug
+Receipt of anticancer chemotherapy within  weeks before the first administration of study drug
+Receipt of anticancer medications, anticancer therapies, or investigational drugs within the defined interval before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
+Receipt of anticancer medications, anticancer therapies, or investigational drugs within protocol-defined intervals before the first administration of study drug.
+Receipt of any vitamin K antagonists, systemic corticosteroids, live vaccines, or treatment with any anticancer medications or investigational drugs within the protocol-defined intervals.
+Receipt of anticancer medications or investigational drugs within protocol-specified intervals
+Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within the Protocol-defined intervals before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within a defined interval before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within the following interval before the first administration of study drug:
+Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug.
+Treatment with other investigational study drug for any indication for any reason, or receipt of anticancer medications within  days before first dose of study drug; subjects must have recovered from AEs due to previously administered therapies.
+Receipt of anticancer medications or investigational drugs within the protocol-defined intervals before the first administration of study drug.
+Receipt of anticancer medications or investigational drugs within protocol-defined intervals before the first administration of study drug